The BSi initiated the Neurotranslational Grant Program to stimulate neurotranslational activities on the JHU campus. The first grants were awarded in September of 2011. This funding opportunity will be announced annually in June, with funding decisions in September/October.
Current funded programs:
Mrgs as potential anti-chronic pain targets
Xinzhong Dong Ph.D., Yun Guan, M.D., Ph.D.; Departments of Neuroscience and Anesthesiology and Critical Care Medicine
Evaluating effects of BACE1 inhibitors on functional recovery from peripheral nerve injury and neuropathic pain
Mohamed H. Farah, Ph.D., Department of Neurology
Development of a High-Throughput Screening Assay for Inhibitors of ACSVL3, a Therapeutic Target in Malignant Glioma
Paul A. Watkins, M.D, Ph.D., Department of Neurology and Kennedy Krieger Institute
In-Silico Design and Analysis of GCP-II inhibitors
Thomas B. Woolf, Ph.D., Department of Physiology
Development of High Content/High Throughput Assays to Measure Photoreceptor Cell Health and Survival in Order to Screen for Retinal Degeneration Therapeutics
Donald J. Zack, M.D., Ph.D., Cynthia A. Berlinicke, Ph.D., Department of Ophthalmology
